Chemomab Therapeutics (CMMB) Free Cash Flow (QoQ) (2018 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 28.71% |
| Sep 30, 2023 | 30.21% |
| Jun 30, 2023 | -4.10% |
| Mar 31, 2023 | -23.11% |
| Dec 31, 2022 | -11.99% |
| Sep 30, 2022 | 7.93% |
| Jun 30, 2022 | -52.00% |
| Mar 31, 2022 | -23.02% |
| Dec 31, 2021 | -17.36% |
| Sep 30, 2021 | 54.81% |
| Jun 30, 2021 | -340.51% |
| Mar 31, 2021 | 16.71% |
| Dec 31, 2020 | -68.95% |
| Sep 30, 2020 | -4.66% |
| Jun 30, 2020 | 54.24% |
| Mar 31, 2020 | 66.04% |
| Dec 31, 2019 | -50.53% |
| Sep 30, 2019 | 4.30% |
| Jun 30, 2019 | -22.96% |
| Mar 31, 2019 | 18.46% |
| Dec 31, 2018 | 40.03% |
| Sep 30, 2018 | -240.70% |
| Jun 30, 2018 | 28.32% |
| Mar 31, 2018 | -41.72% |